BIOTECNOL

• 72110 - Research and experimental development on biotechnology

Biotecnol is a private biopharmaceutical company working in the field of immuno-oncology. Biotecnol develops highly-specific antibody-based immunotherapies which activates and directs the defences of a patient's own immune system, such as their own Killer T-Cells (T-lymphocytes that kill cancer cells) to fight various types of cancers where standard of care treatments have shown little or no benefit... Biotecnol is working in this field of immuno-oncolog y and is using proprietary antibody-based technologies to engineer and develop highly- targeted therapeutic products which utilize a patient's own immune system to fight cancer. These powerful approaches are based on directing or modulating a patient's own T-Cells or NK-Cells to kill the tumours. These T and NK white blood cells are the most potent killing-cells of the human immune system. Other strategies being developed by Biotecnol, include means to modulate key immune-checkpoint regulators for manipulating endogenous anti-tumour..

Also known as: BIOTECNOL LIMITED

Registration numbers: 08696340 (CH)

Primary location: London United Kingdom